Antifungal mechanism of FK463 against Candida albicans and Aspergillus fumigatus.

Cell free 1,3-β-D-glucan synthesis by Candida albicans ATCC90028 (purchased from the American Type Culture Collection, VA, USA) and by Aspergillus fumigatus TIMM0063 (kindly gifted from the Teikyo University Institute of Medical Mycology, Tokyo, Japan) were studied by the methods described below. C. albicans was precultured in YPD broth-A [1% w/v of Bacto-peptone, 0.5% w/v yeast extract, 2% w/v glucose] at 35°C overnight. Preculture was inoculated into fresh same medium (inoculum=10% of total volume) and grown for 6 hours at 35°C with shaking. Cells were harvested by centrifugation

[1]  F. Ikeda,et al.  Efficacy of FK463, a New Lipopeptide Antifungal Agent, in Mouse Models of Disseminated Candidiasis and Aspergillosis , 2000, Antimicrobial Agents and Chemotherapy.

[2]  F. Ikeda,et al.  Efficacy of FK463, a New Lipopeptide Antifungal Agent, in Mouse Models of Pulmonary Aspergillosis , 2000, Antimicrobial Agents and Chemotherapy.

[3]  Koji Kawabata,et al.  In Vitro Activities of a New Lipopeptide Antifungal Agent, FK463, against a Variety of Clinically Important Fungi , 2000, Antimicrobial Agents and Chemotherapy.

[4]  Y. Ohya,et al.  Cloning of the RHO1 gene from Candida albicans and its regulation of beta-1,3-glucan synthesis , 1997, Journal of bacteriology.

[5]  A. Mitchell,et al.  Identification of the FKS1 gene of Candida albicans as the essential target of 1,3-beta-D-glucan synthase inhibitors , 1997, Antimicrobial agents and chemotherapy.

[6]  H. Tabuchi,et al.  Cloning of the Candida albicans homolog of Saccharomyces cerevisiae GSC1/FKS1 and its involvement in beta-1,3-glucan synthesis , 1997, Journal of bacteriology.

[7]  J. Wade Treatment of fungal and other opportunistic infections in immunocompromised patients. , 1997, Leukemia.

[8]  W. Baginsky,et al.  In Vitro Activity of 1,3-β-D-Glucan Synthase Requires the GTP-binding Protein Rho1* , 1996, The Journal of Biological Chemistry.

[9]  N. Morin,et al.  The Saccharomyces cerevisiae FKS1 (ETG1) gene encodes an integral membrane protein which is a subunit of 1,3-beta-D-glucan synthase. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[10]  I..,et al.  Morphological Effects of Lipopeptides against Aspergillus fumigatus Correlate with Activities against (1,3)-β-d-Glucan Synthase , 1994, Antimicrobial Agents and Chemotherapy.

[11]  J. Onishi,et al.  Morphological effects of lipopeptides against Aspergillus fumigatus correlate with activities against (1,3)-beta-D-glucan synthase , 1994, Antimicrobial Agents and Chemotherapy.

[12]  J. Tang,et al.  Characterization and cilofungin inhibition of solubilized Aspergillus fumigatus (1,3)-beta-D-glucan synthase , 1994, Antimicrobial Agents and Chemotherapy.

[13]  J. Tang,et al.  W-1 solubilization and kinetics of inhibition by cilofungin of Candida albicans (1,3)-beta-D-glucan synthase , 1991, Antimicrobial Agents and Chemotherapy.

[14]  C. Selitrennikoff,et al.  Cilofungin (LY121019) inhibits Candida albicans (1-3)-beta-D-glucan synthase activity , 1988, Antimicrobial Agents and Chemotherapy.